This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Invectys. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Anna Kostrzak: Innovator in Cancer Treatment
Introduction
Anna Kostrzak is a prominent inventor based in Paris, France. She has made significant contributions to the field of cancer treatment, particularly through her innovative research and development of therapeutic methods.
Latest Patents
Anna holds a patent for a groundbreaking method of treating fibrosarcoma using a nucleic acid sequence encoding APOBEC3A. This invention relates to the use of a nucleic acid that comprises a sequence encoding an APOBEC3A protein, aimed at preventing or treating tumors in patients. Her work in this area is crucial for advancing cancer therapies.
Career Highlights
Anna is currently associated with Invectys, a company dedicated to developing innovative treatments for cancer. Her role at Invectys allows her to apply her expertise in molecular biology and oncology to create effective therapeutic solutions.
Collaborations
Throughout her career, Anna has collaborated with notable professionals in her field, including Pierre Langlade Demoyen and Simon Wain-Hobson. These collaborations have enriched her research and contributed to the advancement of cancer treatment methodologies.
Conclusion
Anna Kostrzak is a trailblazer in the field of cancer treatment, with her innovative patent and collaborative efforts paving the way for future advancements. Her dedication to improving patient outcomes through scientific research is commendable.